Medical Writing The Medical Writing Business Regulatory Writing: New developments in public disclosure of clinical trials
mew-150pxjpg

Volume 24, Issue 3 - The Medical Writing Business

Regulatory Writing: New developments in public disclosure of clinical trials

Abstract

In April this year, the World Health Organisation (WHO) issued a statement on the public disclosure of clinical trial results (the full statement is available from http://www.who.int/ictrp/results/reporting/en/). In essence, this statement reiterates the previous WHO statement on registration of trial methods prior to initiation and extends it to include the timely publication of results, both in clinical trial registries and in peer reviewed journals. The aim is to ensure that negative results are not underreported, thereby distorting efficacy conclusions derived from publicly available data. The statement also calls for sponsors to make the results of past trials available. Finally, the statement suggests more rigorous identification of trial registry identification in subsequent publications and data sharing initiatives, presumably to make meta-analyses easier. The statement was accompanied by a detailed rationale published in PLoS1 and a commentary, also in PLoS,2 by Ben Goldacre, a prominent campaigner for full disclosure of clinical trial results.

References

  1. Moorthy VS, Karam G, Vannice KS, Kieny M-P. Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results. PLoS Med. 2015;12(4):e1001819.
  2. Goldacre B. How to get all trials reported: audit, better data, and individual accountability. PLoS Med. 2015;12(4):e1001821.
  3. Anderson ML, Chiswell K, Peterson ED, Tasneem A, Topping J, Califf RM. Compliance with results reporting at ClinicalTrials.gov. N Engl J Med. 2015;372(11):1031–9.
  4. Goodyear M. Learning from the TGN1412 trial. BMJ. 2006;332(7543):677–8.
  5. Jones CW, Handler L, Crowell KE, Keil LG, Weaver MA, Platts-Mills TF. Non-publication of large randomized clinical trials: cross sectional analysis. BMJ. 2013;347:f6104.

Search

Articles

In this issue… The Medical Writing Business
President's Message
Setting up and running a medical writing company
For the greater good…Can agency competitors cooperate to advance medical publication practices?
The Section of Scientific Publications at the Texas Heart Institute
Is cheap outsourcing a threat to your career?
Successfully outsourcing medical writing
Freelancing – Are you ready to go solo?
News from the EMA
European Science Editing: May 2015 picks
Profile: An interview with Dawn Bentley: How personal branding can advance your professional career!
The Webscout
In the Bookstores
Regulatory Writing: New developments in public disclosure of clinical trials
Lingua Franca and Beyond
Gained in Translation
HIV research fraudster handed stiff prison sentence
English Grammar and Style: Good Writing Practice
Did you know that EMWA has an archive of webinar material on our website?
Medical Communications
Out On Our Own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Editorial Manager

  • Victoria White (Tampa, Florida, USA)
show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: